Earnings Outlook For ImmunoPrecise Antibodies
Earnings Outlook For ImmunoPrecise Antibodies
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).ImmunoPrecise Antibodies (NASDAQ:IPA) is set to give its latest quarterly earnings report on Thursday, 2024-03-14. Here's what investors need to know before the announcement.
ImmunoPrecise Antibodies（納斯達克股票代碼：IPA）定於2024-03-14星期四發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。
Analysts estimate that ImmunoPrecise Antibodies will report an earnings per share (EPS) of $-0.07.
分析師估計，ImmunoPrecise Antibodies將公佈的每股收益（EPS）爲-0.07美元。
ImmunoPrecise Antibodies bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
ImmunoPrecise 抗體多頭希望聽到該公司宣佈他們不僅超過了這一預期，而且還爲下一季度提供積極的指導或預測的增長。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投資者應注意，有時對股票價格影響最大的不是收益超過或失敗，而是指導方針（或預測）。
Past Earnings Performance
過去的收益表現
Last quarter the company beat EPS by $0.03, which was followed by a 4.83% drop in the share price the next day.
上個季度，該公司每股收益超過0.03美元，隨後第二天股價下跌了4.83％。
Here's a look at ImmunoPrecise Antibodies's past performance and the resulting price change:
以下是ImmunoPrecise Abtions過去的表現以及由此產生的價格變化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.100 | -0.15 | -0.13 | -0.17 |
| EPS Actual | -0.074 | -0.10 | -0.15 | -0.14 |
| Price Change % | -5.0% | -12.0% | -1.0% | -2.0% |
| 季度 | 2024 年第二季度 | 2024 年第一季度 | 2023 年第四季度 | 2023 年第三季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.100 | -0.15 | -0.13 | -0.17 |
| 實際每股收益 | -0.074 | -0.10 | -0.15 | -0.14 |
| 價格變動% | -5.0% | -12.0% | -1.0% | -2.0% |
Stock Performance
股票表現
Shares of ImmunoPrecise Antibodies were trading at $1.64 as of March 12. Over the last 52-week period, shares are down 50.45%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
截至3月12日，ImmunoPrecise Antibodies的股票交易價格爲1.64美元。在過去的52週中，股價下跌了50.45％。鑑於這些回報率通常爲負數，長期股東可能會對本次業績感到不滿。
To track all earnings releases for ImmunoPrecise Antibodies visit their earnings calendar on our site.
要追蹤ImmunoPrecise Antibodies的所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
